Health Canada OKs Using Ferriprox for Iron Overload

Health Canada OKs Using Ferriprox for Iron Overload

309608

Health Canada OKs Using Ferriprox for Iron Overload

Health Canada has expanded its approval of Chiesi Global Rare Diseases’ iron-binding oral treatment Ferriprox (deferiprone) to patients who have blood transfusion-induced iron overload due to sickle cell disease (SCD) or other anemias. The decision comes about five months after the U.S. Food and Drug Administration (FDA) approved Ferriprox for the same indication in the U.S. and one month after its approval in Brazil. The therapy was approved in Canada previously for people with thalassemia major,…

You must be logged in to read/download the full post.